Corrigendum: Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury via Regulating PI3K/AKT Inhibited HIF-1a/VEGF Signaling Pathway

Weijie Xie; Ping Zhou; Muwen Qu; Ziru Dai; Xuelian Zhang; Chenyang Zhang; Xi Dong; Guibo Sun; Xiaobo Sun

doi:10.3389/fphar.2020.01312

Corrigendum: Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury via Regulating PI3K/AKT Inhibited HIF-1a/VEGF Signaling Pathway

Front Pharmacol. 2020 Oct 23:11:1312. doi: 10.3389/fphar.2020.01312. eCollection 2020.

Authors

Weijie Xie¹, Ping Zhou¹, Muwen Qu², Ziru Dai¹, Xuelian Zhang¹, Chenyang Zhang¹, Xi Dong¹, Guibo Sun¹, Xiaobo Sun¹

Affiliations

¹ Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
² Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2020.00695.].

Keywords: apoptosis; diabetic retinopathy; ginsenoside Re; hypoxia-inducible factor-1-alpha; oxidative stress; phosphoinositide 3-kinase/AKTT; vascular endothelial growth factor.

Publication types

Published Erratum